Despite the disruptions caused by COVID-19, the FDA’s Center for Drug Evaluation and Research (CDER) approved 53 novel therapeutics in 2020. This is the second highest total ever, falling just short of 2018’s all-time high of 59, and tying with the 1996 approval cohort.

Para acessar a publicação na íntegra clique aqui
Fonte: NaTure RevIewS | DRUg DISCOVERY volume 20 | February 2021 | 85